anaplastic meningioma | GenomeWeb

anaplastic meningioma

The firm, Proteomedix Frontiers, has developed SRM-MS assays for more than 400 proteins that could be important to drug development efforts. It plans to offer them to pharma researchers both as kits and through agreements with contract research organizations.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.